Medprin Regenerative Medical Technologies Co.,Ltd.’s Net Profit Dropped 20% in 2022

Medprin Regenerative Medical Technologies Co.,Ltd. (广州迈普再生医学科技股份有限公司) (301033.SZ) reported a net profit of 35.7 million yuan in 2022, down 20% year-on-year.

Meanwhile, the company posted 195.3 million yuan in revenue, up 27% year-on-year.

At the end of the reporting period, it had 744.9 million yuan in total assets and 142.3 million yuan in total liabilities, with a liability-to-asset ratio of 19.1%.